Product NDC: | 0008-0833 |
Proprietary Name: | Effexor |
Non Proprietary Name: | VENLAFAXINE HYDROCHLORIDE |
Active Ingredient(s): | 75 mg/1 & nbsp; VENLAFAXINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0008-0833 |
Labeler Name: | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020699 |
Marketing Category: | NDA |
Start Marketing Date: | 19971101 |
Package NDC: | 0008-0833-22 |
Package Description: | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0008-0833-22) |
NDC Code | 0008-0833-22 |
Proprietary Name | Effexor |
Package Description | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0008-0833-22) |
Product NDC | 0008-0833 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | VENLAFAXINE HYDROCHLORIDE |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19971101 |
Marketing Category Name | NDA |
Labeler Name | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
Substance Name | VENLAFAXINE HYDROCHLORIDE |
Strength Number | 75 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |